Matches in Nanopublications for { ?s ?p "[Pharmacological inhibition of the PI3K/Akt pathway in breast cancer cells reduces DNA-binding activity of Runx2 with concomitant reduction in the expression of metastasis-related Runx2 target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP539872.RATVcL0R63ZuIwV3wjSk95NAQVWEFXovvlmLw7hyNcGyQ130_assertion description "[Pharmacological inhibition of the PI3K/Akt pathway in breast cancer cells reduces DNA-binding activity of Runx2 with concomitant reduction in the expression of metastasis-related Runx2 target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539872.RATVcL0R63ZuIwV3wjSk95NAQVWEFXovvlmLw7hyNcGyQ130_provenance.
- NP325703.RAHXTwZYQYYU8t7tt4Di6P1QcsHTBImMCx3UH8wh7TIoI130_assertion description "[Pharmacological inhibition of the PI3K/Akt pathway in breast cancer cells reduces DNA-binding activity of Runx2 with concomitant reduction in the expression of metastasis-related Runx2 target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325703.RAHXTwZYQYYU8t7tt4Di6P1QcsHTBImMCx3UH8wh7TIoI130_provenance.
- NP457979.RAySvy6tQoN4VfZKUxkKoKFnqQmlMrfSCoxJbYfp_C0eI130_assertion description "[Pharmacological inhibition of the PI3K/Akt pathway in breast cancer cells reduces DNA-binding activity of Runx2 with concomitant reduction in the expression of metastasis-related Runx2 target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP457979.RAySvy6tQoN4VfZKUxkKoKFnqQmlMrfSCoxJbYfp_C0eI130_provenance.
- assertion description "[Pharmacological inhibition of the PI3K/Akt pathway in breast cancer cells reduces DNA-binding activity of Runx2 with concomitant reduction in the expression of metastasis-related Runx2 target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pharmacological inhibition of the PI3K/Akt pathway in breast cancer cells reduces DNA-binding activity of Runx2 with concomitant reduction in the expression of metastasis-related Runx2 target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pharmacological inhibition of the PI3K/Akt pathway in breast cancer cells reduces DNA-binding activity of Runx2 with concomitant reduction in the expression of metastasis-related Runx2 target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pharmacological inhibition of the PI3K/Akt pathway in breast cancer cells reduces DNA-binding activity of Runx2 with concomitant reduction in the expression of metastasis-related Runx2 target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP674261.RAGhETHuDkQNfxhlm5pZefhRjr50VOGKGXGXHlaqKSMls130_assertion description "[Pharmacological inhibition of the PI3K/Akt pathway in breast cancer cells reduces DNA-binding activity of Runx2 with concomitant reduction in the expression of metastasis-related Runx2 target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674261.RAGhETHuDkQNfxhlm5pZefhRjr50VOGKGXGXHlaqKSMls130_provenance.